Aspirin resistance: Prevalence and clinical outcome in Egypt
Introduction: The antiplatelet drug aspirin is considered as a cornerstone in medical treatment of patients with CV or cerebrovascular diseases. Despite its use, a significant number of patients had recurrent adverse ischemic events. Inter-individual variability of platelet aggregation in response t...
Main Authors: | Ahmed Salah, Mohammed El-Desuky, Amal Rizk, Amr El-Hadidy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2015-04-01
|
Series: | Egyptian Journal of Critical Care Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090730314000309 |
Similar Items
-
The association between aspirin resistance and extent and severity of coronary atherosclerosis
by: Serkan Kahraman, et al.
Published: (2018-12-01) -
Aspirin resistance and ischemic heart disease on Iranian experience
by: Masoumeh Sadeghi, et al.
Published: (2012-01-01) -
Effects of Preoperative Aspirin Use on Mortality in Coronary Artery Bypass Grafting Patients
by: E Jazayeri, et al.
Published: (2008-09-01) -
Effects of preoperative aspirin use on mortality in Coronary Artery Bypass grafting patients
by: M Abbaszadeh, et al.
Published: (2008-12-01) -
Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan
by: Yu Ito, et al.
Published: (2020-05-01)